Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome

This study is currently recruiting participants.
Verified January 2012 by Vrije Universiteit Brussel
Sponsor:
Collaborators:
Artesis University College, Antwerp
Universiteit Antwerpen
University Hospital, Antwerp
Information provided by (Responsible Party):
Jo Nijs, Vrije Universiteit Brussel
ClinicalTrials.gov Identifier:
NCT01512342
First received: January 10, 2012
Last updated: January 13, 2012
Last verified: January 2012

January 10, 2012
January 13, 2012
August 2011
June 2012   (final data collection date for primary outcome measure)
the change in score on the Canadian Occupational Performance Measure (COPM) [ Time Frame: measured at baseline (week 1) and post-treatment (week 5) ] [ Designated as safety issue: No ]
well-validated, reliable and frequently used outcome measure semi-structered interview
Same as current
Complete list of historical versions of study NCT01512342 on ClinicalTrials.gov Archive Site
  • the change in subscale scores on the Medical Outcomes Short Form 37 Health Status Survey (SF-36) [ Time Frame: measured at baseline (week 1) and post-treatment (week 5) ] [ Designated as safety issue: No ]
    The SF-36 assesses functional status and well-being or quality of life. The SF-36 has been documented to have reliability and validity in a wide variety of patient populations and it is the most frequently used measure in CFS research.
  • the change in Ckecklist Individual Strength (CIS) [ Time Frame: measured at baseline (week 1) and post-treatment (week 5) ] [ Designated as safety issue: No ]
    The CIS aims at assessing the subjective fatigue experience, concentration difficulties, motivation and physical activity. Higher scores on the CIS correspond to severe fatigue, many concentration difficulties, problems with motivation and a low level of physical activity. Its psychometric properties are well established.
  • the change in CFS Symptom List [ Time Frame: measured at baseline (week 1) and post-treatment (week 5) ] [ Designated as safety issue: No ]
    The CFS Symptom List is a self-reported measure for assessing symptom severity in CFS patients. In order to assess the severity of the symptoms included in the CFS Symptom List, visual analogue scales (100 mm) are used. Psychometric work supporting the use of the CFS Symptom List has been published.
  • the change in autonomic activity at rest and following 3 activities of daily living [ Time Frame: measured at baseline (week 1) and post-treatment (week 5) ] [ Designated as safety issue: No ]
    The 3 activities of daily living entail writing a standardized test on a laptop computer, ironing, and climbing 26 flights of stairs. For measuring autonomic activity, the Nexus 10 device (Mind Media, the Netherlands) will be used. Skin conductance, body temperature, heart rate, blood volume pressure and heart rate variability will be measured continuously in real time during a 2 minutes period, with the patient sitting on a chair (back supported and hands resting on legs). Electrodes will be placed on the left hand in all patients.
Same as current
Not Provided
Not Provided
 
Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome
Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome: Randomized Controlled Clinical Trial

Given the lack of evidence in support of pacing self-management for patients with chronic fatigue syndrome (CFS), it is examined whether physical behavior and health status of patients with CFS improve in response to a pacing self-management program. The effects of pacing will be compared with those observed when applying relaxation therapy to patients with CFS.

Given the lack of evidence in support of pacing self-management for patients with chronic fatigue syndrome (CFS), it is examined whether physical behavior and health status of patients with CFS improve in response to a pacing self-management program. The effects of pacing will be compared with those observed when applying relaxation therapy to patients with CFS.

According to the power calculation, 36 patients fulfilling the 1994 Centre for Disease Control and Prevention criteria for the diagnosis of chronic fatigue syndrome (CFS) will be randomized to either 3 weeks of pacing activity self-management or relaxation therapy. Both treatment groups will receive 3 weekly sessions spread over 3 consecutive weeks. All treatments will be delivered by occupational therapists or physiotherapists. One treatment session lasts for about 45 minutes each.

Outcome measures include the Canadian Occupational Performance Measure (COPM), Medical Outcomes Short Form 37 Health Status Survey (SF-36), Checklist Individual Strength (CIS), CFS Symptom List and autonomic activity at rest and following 3 activities of daily living (writing a standardized test on a laptop computer, ironing, and climbing 26 flights of stairs). For measuring autonomic activity, the Nexus 10 device (Mind Media, the Netherlands) will be used. Skin conductance, body temperature, heart rate, blood volume pressure and heart rate variability will be measured continuously in real time during a 2 minutes period, with the patient sitting on a chair (back supported and hands resting on legs). Electrodes will be placed on the left hand in all patients.

Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Chronic Fatigue Syndrome
  • Behavioral: Pacing
    3 one-on-one sessions weekly for 3 consecutive weeks
    Other Names:
    • activity self-management
    • activity management
    • adaptive pacing
  • Behavioral: relaxation therapy
    3 one-on-one sessions weekly for 3 consecutive weeks
    Other Names:
    • stress managament
    • Jacobson relaxation
    • visualisation
    • Schultz relaxation
  • Experimental: Pacing
    The pacing self-management program focussed on teaching the patient to estimate their current physical capabilities prior to commencing an activity. In order to appropriately pace activities (daily activities and exercise bouts), CFS patients were learned to estimate their current physical capabilities prior to commencing an activity, keeping in mind the regular fluctuating nature of their symptoms. The activity duration used within the program was less than that reported by the patient so to account for typical overestimations made by the patient. Each activity block was interspersed with breaks, with the length of this break equating to the duration of the activity.
    Intervention: Behavioral: Pacing
  • Active Comparator: relaxation therapy
    Relaxation therapy comprised of education about the role of stress in CFS biology, and the opportunities stress management provides to handle this issue. Patients were then taught how to apply stress management techniques like Jacobson relaxation skills, Schultz relaxation skills, visualization, etc.
    Intervention: Behavioral: relaxation therapy

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
36
August 2012
June 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • adult
  • age range between 18 and 65 years of age
  • female gender
  • willing to sign informed consent form
  • fulfilling the 1994 Centre for Disease Control and Prevention criteria for the diagnosis of chronic fatigue syndrome

Exclusion Criteria:

- Not fulfilling each of the inclusion criteria listed above.

Female
18 Years to 65 Years
No
Contact: Jo Nijs, PhD +3226292222 Jo.Nijs@vub.ac.be
Contact: Daphne Kos, PhD +3236418265 daphne.kos@artesis.be
Belgium
 
NCT01512342
PacingCFS, Artesis University College
No
Jo Nijs, Vrije Universiteit Brussel
Vrije Universiteit Brussel
  • Artesis University College, Antwerp
  • Universiteit Antwerpen
  • University Hospital, Antwerp
Study Director: Daphne Kos, PhD Artesis University College Antwerp, Belgium
Vrije Universiteit Brussel
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP